EUCTR2010-020886-26-DE进行中（未招募）不适用
Prospective, open-label, non-randomized, single-arm, multi-center dose titration study to investigate the safety and efficacy of NT 201 in subjects deemed to require total body doses of 800 U of NT 201 during the course of the study for the treatment of upper and lower limb spasticity of the same body side due to cerebral causes - TOWER
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age from 18-80 yrs
- •-Upper and lower limb spasticity of the same body side due to cerebral causes
- •-Time since event leading to spasticity in the target body side greater than 12 weeks
- •-Need for 800 units Botulinum toxin type A
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Body weight below 50kg
- •-Fixed contractures of the target joint
- •-Generalized disorders of muscle activity like Myasthenia gravis that preclude use of Botulinum toxin type A
- •-Infection at the injection site
研究者
相似试验
进行中（未招募）
不适用
Dose titration study to evaluate efficacy and safety of Botulinum toxin type A to treat spasticity in the leg and armEUCTR2010-020886-26-ESMerz Pharmaceuticals GmbH150
进行中（未招募）
不适用
Dose titration study to evaluate efficacy and safety of Botulinum toxin type A to treat spasticity in the leg and armSpasticity of the upper and lower limb of the same body side due to cerebral causesMedDRA version: 17.1Level: LLTClassification code 10058977Term: Spastic paresisSystem Organ Class: 100000004852EUCTR2010-020886-26-PTMerz Pharmaceuticals GmbH150
进行中（未招募）
1 期
Prospective study to investigate the efficacy and safety of IncobotulinumtoxinA in children deemed to require a total body dose up to 22U/kg (maximum dose 550U) during the study period for the treatment of upper and lower limb spasticity due to cerebral palsyMultifocal spasticity of the upper and lower limb due to cerebral palsyMedDRA version: 20.0Level: PTClassification code 10028335Term: Muscle spasticitySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: LLTClassification code 10033560Term: Palsy cerebralSystem Organ Class: 100000004850EUCTR2019-003559-12-ITAZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA30
进行中（未招募）
不适用
Dose titration study to evaluate efficacy and safety of Botulinum toxin type A to treat spasticity in the leg and armEUCTR2010-020886-26-ITMERZ PHARMACEUTICALS GMBH150
尚未招募
不适用
An Open Phase 3 study of IV-Globulin SN Inj.10% to Treat Immune ThrombocytopeniaDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0001026Green Cross70